Related Experiment Video
Updated: Apr 17, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.9K
Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas
Elizabeth H Dorfman1, Susan Brown Trinidad, Chelsea T Morales
1Institute for Public Health Genetics, University of Washington, Seattle, WA, USA.
Pharmacogenomics
|February 26, 2015
Summary
Healthcare providers in rural and tribal areas see potential in pharmacogenomic testing but face unique challenges. Barriers include cost, patient acceptance, and community considerations for successful implementation.
Area of Science:
- Genetics
- Healthcare Management
- Clinical Pharmacy
Background:
- Limited research exists on pharmacogenomic test implementation in non-urban settings.
- Previous studies primarily focused on large, urban medical centers.
Purpose of the Study:
- To explore the clinical feasibility of pharmacogenomic testing in small metropolitan, rural, and tribal practice settings.
- To identify unique barriers and facilitators for pharmacogenomic test adoption in diverse community contexts.
Main Methods:
- Qualitative study involving interviews with 17 healthcare providers in western Montana.
- Exploration of provider perspectives on pharmacogenomic testing implementation.
Main Results:
- Providers expressed optimism regarding pharmacogenomic testing's potential benefits.
- Key barriers identified include cost, patient adherence, acceptability, and testing turnaround time.
- Tribal settings highlighted specific concerns related to genetic sensitivity and community leadership approval.
Conclusions:
- Implementation of pharmacogenomic tests may differ significantly across small metropolitan, rural, and tribal communities.
- These differences could impact the widespread adoption and utilization of pharmacogenomic testing.
- Addressing community-specific needs is crucial for successful pharmacogenomic test integration.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
194
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
194
01:27Pharmacogenetics of Drug Metabolism: Overview
157
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
157
01:29Pharmacogenomics: Identification of New Drug Targets
95
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95
01:27Principles of Pharmacogenetics: Types of Genetic Variants
119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
132
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
01:12Analysis of Population Pharmacokinetic Data
953
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
953